Ophthalmological formulations for the prevention of a coronavirus infection
AssigneeUniversity of South Florida
InventorsVijaykumar Sutariya, Srinivas Tipparaju, Kevin Sneed, Manas Biswal, Ramesh Ayyala, Radouil Tzekov
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for an ophthalmological composition comprising remdesivir and an ophthalmologically suitable carrier, and the use thereof for treating and preventing a coronavirus infection and treating conjunctivitis.
Claims18
An ophthalmological composition comprising a nanoparticle and ophthalmologically suitable carrier, wherein the nanoparticle comprises remdesivir, or a pharmaceutically acceptable salt thereof, in a concentration of about 15 wt %, and wherein the nanoparticle has an average diameter of from 200 to 250 nm, further wherein the nanoparticle comprises poly(lactic acid-co-glycolic-acid) carboxylic acid (PLGA-COOH).
Dependencies are inferred from the claim text.